Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-12-22

FDA Approved: CURIST ALLERGY RELIEF — Original Application (Little Pharma, Inc.)

View source ↗

Summary

FDA approves CURIST ALLERGY RELIEF through an original ANDA for cetirizine hydrochloride, authorizing the generic for allergy symptom relief.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CURIST ALLERGY RELIEF (cetirizine hydrochloride)

Snippet

ORIG AP for CURIST ALLERGY RELIEF (CETIRIZINE HYDROCHLORIDE)